Sole Source Justification -CU-64 Detectnet-Radiopharmaceuticals._Redacted-sam.gov.pdf

This is a Sole Source Justification document for the Department of Veterans Affairs (VA) to acquire Cu-64 Dotatate radiopharmaceuticals from Cardinal Health 414, LLC. The procurement is for a new firm fixed price Indefinite Delivery Indefinite Quantity (IDIQ) contract with a base year and four one-year ordering periods, effective 11/15/24. The VA's Central Arkansas Veterans Healthcare System (CAVHS) in Little Rock, Arkansas requires Cu-64 Dotatate in pre-filled syringes for positron emission tomography-computed tomography (PET CT) imaging, with an estimated annual quantity of 52 units.

The document justifies the sole source procurement by highlighting that Curium US LLC manufactures the Cu-64 Dotatate, but does not deliver the product directly, while Cardinal Health 414, LLC is the only nuclear pharmacy in the local area capable of delivering the radiopharmaceuticals with the required nuclear pharmacy licenses, courier capabilities, and ability to prepare patient-specific doses. Market research was conducted, including a 15-day Notice of Intent (NOI) posting, which yielded no competitive responses. The total estimated acquisition value was redacted, but similar awarded procurements for nuclear medicine radiopharmaceuticals range from approximately $1.3 million to $4.3 million. The contract aims to prevent delays in nuclear medicine PET CT imaging studies at the CAVHS facility.